MIT engineers have created tiny "mini livers" that can be injected into the body. This breakthrough could change how doctors treat liver disease. The new injectable tissues, called "satellite livers," successfully took over liver functions for at least eight weeks in mice. This offers a potential lifeline for more than 10,000 Americans waiting for a liver transplant. The study, led by Professor Sangeeta Bhatia and postdoc Vardhman Kumar, appeared in the journal Cell Biomaterials this month.[news+8]
A New Approach to Liver Failure
Many people suffer from chronic liver disease. They often need a liver transplant, but donor organs are scarce. Also, some patients are too sick to handle the major surgery a transplant requires. The MIT team designed these mini livers to help these patients without invasive surgery.[news+6]
The mini livers are engineered tissue grafts. They consist of hepatocytes, which are the main functional cells of the liver. These cells are mixed with tiny hydrogel microspheres and supportive fibroblast cells. Scientists inject this mixture using a syringe guided by ultrasound.[news+6]
Sangeeta Bhatia, a professor at MIT and senior author of the study, explained the concept. "We think of these as satellite livers," Bhatia said. "If we could deliver these cells into the body, while leaving the sick organ in place, that would provide booster function."This means the injected mini livers could support a failing organ.[news+4]
How the Mini Livers Work Inside the Body
The hydrogel microspheres play a critical role. They have special properties that let them act like a liquid when injected. Once inside the body, they regain their solid structure. This helps the injected liver cells stay together and connect with nearby blood vessels.[news+5]
Fibroblast cells are also part of the mixture. These supportive cells help the hepatocytes survive and encourage new blood vessels to grow into the tissue. Over time, blood vessels grow into the grafted area. This helps the injected liver cells stay healthy and function properly.[news+5]
In tests with mice, researchers injected the mini livers into fatty tissue in the belly. This area is called the perigonadal adipose tissue. Vardhman Kumar, the lead author of the study, noted that the location does not have to be near the original liver. "For a vast majority of liver disorders, the graft does not need to sit close to the liver," Kumar said.Future injections could also go into the spleen or near the kidneys.[news+4]
Kumar also highlighted the importance of the microspheres. "If the cells are injected in the absence of these spheres, they would not integrate efficiently with the host," Kumar explained. "But these microspheres provide the hepatocytes with a niche where they can stay localized and become connected to the host circulation much faster."This engineered environment is key for the cells to survive and work.[news+3]
Promising Results and Future Steps
The results in mice were highly encouraging. The injected liver cells remained alive and functional for at least eight weeks, which was the full length of the study. During this time, the mini livers produced many essential enzymes and proteins, just like a healthy liver. This shows they can perform critical liver functions.[news+8]
This technology could potentially offer a long-term treatment option for liver disease. It could also act as a temporary solution, providing support until a donor organ becomes available. "The way we see this technology is it can provide an alternative to surgery, but it can also serve as a bridge to transplantation," Kumar said.[news]
A current challenge is that patients would likely need to take immunosuppressive drugs. These drugs prevent the body from rejecting the new cells. However, researchers are already working on solutions. They are exploring ways to develop "stealthy" hepatocytes that can avoid the immune system. Another idea is to use the hydrogel microspheres to deliver immunosuppressants directly to the injected area.[news]
The MIT team plans to continue testing these mini liver grafts in animal models. The next step will be to move towards clinical trials. These trials will evaluate the safety and effectiveness of the technology in humans. The goal is to make this innovative treatment available to patients in need.[nationaltoday]
This injectable mini liver technology represents a significant step forward in regenerative medicine. It offers new hope for thousands of people suffering from liver failure and awaiting transplants.
